Literature DB >> 6846430

Prognostic factors in early invasive carcinoma of the uterine cervix. A clinical, histopathologic, and statistical analysis of 343 cases.

G Larsson, P Alm, B Gullberg, H Grundsell.   

Abstract

Three hundred forty-three cases of early invasive carcinoma of the uterine cervix were analyzed. Depth of infiltration and lateral extension of the tumors varied between 0.2 and 9.0 mm and 0.4 and 17.2 mm and were found to be of no prognostic importance. A multivariate statistical analysis revealed several risk factors: an epithelialized portio at diagnosis, suspected or evident tumor invasion in capillary-like spaces, absence of tumor-free margins at conization, and treatment with conization or simple hysterectomy, especially in the presence of the above-mentioned factors. Tumors of a large cell keratinizing type were prognostically favorable. Confluent growth was not associated with increased risk of recurrence or death from recurrence. Cervical biopsies proved to be inadequate as diagnostic material. Recurrences were almost always local and developed late. In absence of risk factors conization is sufficient treatment. In the presence of risk factors treatment should be the same as that performed for frankly invasive Stage IB carcinomas.

Entities:  

Mesh:

Year:  1983        PMID: 6846430     DOI: 10.1016/0002-9378(83)91043-8

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  3 in total

Review 1.  Management of gynaecological cancers.

Authors:  A Melville; A Eastwood; J Kleijnen; H Kitchener; P Martin-Hirsch; L Nelson
Journal:  Qual Health Care       Date:  1999-12

2.  An evaluation of chemotherapy in patients with cancer of the cervix and lymph node metastases.

Authors:  H T Ng; C C Yuan; Y Y Kan; E S Ho; M S Yen; K C Chao
Journal:  Arch Gynecol Obstet       Date:  1995       Impact factor: 2.344

3.  Neoangiogenesis in early cervical cancer: correlation between color Doppler findings and risk factors. A prospective observational study.

Authors:  Matias Jurado; Rosendo Galván; Rafael Martinez-Monge; Jesús Mazaira; Juan Luis Alcazar
Journal:  World J Surg Oncol       Date:  2008-11-25       Impact factor: 2.754

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.